# PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

> **NCT07700121** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 10 (estimated)

## Conditions studied

- Unresectable or Metastatic Melanoma

## Interventions

- **PROCEDURE:** Resection of PET (high) and PET (low) Tumors
- **BIOLOGICAL:** Lifileucel Manufacturing Clinical v Research
- **DRUG:** Chemotherapy Regimen
- **BIOLOGICAL:** Lifileucel Infusion
- **DRUG:** IL-2
- **PROCEDURE:** CD8 PET

## Key facts

- **NCT ID:** NCT07700121
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700121, "PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*